Results from both cell culture experiments and animal studies provide evidence that blocking endogenous LINGO-1 by LINGO-1 antagonists or gene knockouts promote oligodendrocytic differentiation, axonal integrity and remyelinisation in experimental models of multiple sclerosis [23]. This evidence concerns the gene LINGO1 and multiple sclerosis.